a uncommon, aggressive mind tumor


Gliomas develop within the glial cells that encompass neurons and assist them perform. Gliomas can have an effect on motor and neurological talents and capabilities, together with cognitive capabilities. They might additionally have an effect on the character of the affected person.

The sort of tumor differs from so-called secondary mind tumors, that are metastases that develop from one other most cancers positioned in one other organ. Glioma can have an effect on individuals of all ages, together with youngsters, adolescents, and younger adults.

Gliomas characterize about 20% of all mind and CNS tumors1

Glioma is taken into account a uncommon most cancers as a result of it impacts lower than 6 out of 100,000 individuals yearly2.

Gliomas are available a wide range of varieties relying on the kind of cell affected. Gliomas are divided into low-grade and extra aggressive high-grade tumors.

The invention of mutations in isocitrate dehydrogenase (IDH) in 2008 began a brand new period within the molecular classification of gliomas. Gliomas with IDH mutations (mIDH gliomas) at the moment are identified to be molecularly completely different than glioblastoma – probably the most aggressive type of glioma. There are two varieties of IDH mutant tumors: IDH mutant astrocytoma, and oligodendroglioma.

Most sufferers with IDH-mutant gliomas current to medical consideration after a seizure3,4, or the tumors are found by the way when mind magnetic resonance imaging (MRI) is obtained for analysis of complaints unrelated to the tumor 5,6.

Key figures – within the US

18.12%

of diffuse gliomas have an IDH (IDH1 or 2) mutation

At the very least 2,400

new instances of mutant IDH1/2 glioma have been recognized in 20197

The primary types of glioma 

The 2021 WHO classification of tumors of the central nervous system defines the next three distinct classes of adult-type diffuse gliomas primarily based on any mutations recognized.

a uncommon, aggressive mind tumor
Illustrated infographic presenting the Glioma 2021 WHO grading

IDH mutation is now thought of as the first key driver of analysis and grading doesn’t solely depend on histology.

The problem is due to this fact to detect the tumor, take away it and characterize it as early as doable. Therefore the significance of figuring out danger components and recognizing signs.

So far, no exact reason for glioma has been recognized. Nonetheless, sure components could enhance the danger of growing a glioma:

  • Age.Sufferers are younger with a median age at analysis from 36 to 45 years (astrocytomas/ oligodendroglioma)1,8
    • IDH1/2-mutant glioma incidence is greater in youthful adults and reduces with advancing age9
    • Astrocytomas normally happen in youthful individuals in comparison with oligodendroglioma1
  • Publicity to ionizing radiation, notably radiotherapy as a part of most cancers therapy.
  • Sure hereditary syndromes or ailments.

Signs rely on tumor location, dimension and development. There are a variety of frequent indicators which will point out the presence of a glioma:

  • Epileptic seizures: these are among the many most frequent signs of gliomas, notably low-grade ones.
  • Neurological issues: imaginative and prescient issues, problem talking or understanding, lack of energy or sensitivity in a single a part of the physique, behavioral modifications or irritability, reminiscence loss, numbness or weak point within the decrease a part of the physique.
  • Signs related to elevated strain within the mind: complications, nausea, vomiting, double imaginative and prescient, drowsiness.
  • Thromboembolic occasions (clot formation within the bloodstream): motor deficits and/or immobility.

These medical indicators ought to immediate the affected person to hunt immediate medical consideration. They might even be the manifestation of different well being issues. Solely particular medical examinations can set up a exact analysis.

The molecular characterization, histology and grading of a glioma assist docs decide the suitable therapy plan. IDH1/2m diffuse gliomas usually are not curable and principally reworking into aggressive enhancing glioma10.

Preliminary administration of IDH1/2-mutant adult-type diffuse glioma is surgical resection, when doable, which has retrospectively proven enhancements in survival. Present post-operative normal of take care of sufferers who’re liable to early illness development is chemoradiotherapy11,12.

Therapy is related to radiation-induced neurocognitive dysfunction, chemotherapy-associated DNA hypermutation and different toxicities11.

Sufferers with IDH1/2-mutant adult-type diffuse glioma could select energetic statement (watch and wait) as an alternative of chemotherapy or radiation remedy, if situations allow11.


[1] Ostrom QT et al. Neuro Oncol 2022;24( Suppl 5):v1 95
[2] Gatta G, van der Zwan JM, Casali PG, Siesling S, Dei Tos AP, Kunkler I, Otter R, Licitra L, Mallone S, Tavilla A, Trama A, Capocaccia R; RARECARE working group. Uncommon cancers usually are not so uncommon: the uncommon most cancers burden in Europe. Eur J Most cancers. 2011 Nov;47(17):2493-511. doi: 10.1016/j.ejca.2011.08.008. Epub 2011 Oct 25. PMID: 22033323.
[3] Schiff  D. Low-grade gliomas. Continuum. 2015; 21(2 Neuro-oncology):345–354.
[4] Gonzalez  Castro  LN, Milligan  TA. Seizures in sufferers with most cancers. Most cancers. 2020; 126(7):1379–1389
[5] Morris  Z, Whiteley  WN, Longstreth  WT, Jr, et  al. Incidental findings on mind magnetic resonance imaging: systematic assessment and metaanalysis. BMJ. 2009; 339:b3016.
[6] Opoku-Darko M, Eagles ME, Cadieux M, Isaacs AM, Kelly JJP. Pure historical past and development patterns of by the way found diffusely infiltrating lowgrade gliomas: a volumetric research. World Neurosurg. 2019; 132:e133–e139
[7] Ostrom QT, et al. J Neuro-oncol. 2023 Oct;25(Supplement_4):iv1-iv99.
[8] Miller JJ et al, Neuro Oncol , 2023 Jan; 25 (1):4 25
[9] Miller JJ et al. Neuro Oncol2023;noac207
[10] Youssef et al, Curr Neurol Neurosci Rep, 2020; 20(7): 21.
[11] Weller M et al. Nat Rev Clin Oncol 2021;18:170–86. 
[12] NasanyRA et al. CurrNeurol NeurosciRep 2023;23:225–33.

Hot Topics

Related Articles